Business Context and Reporting Period
Company: SANUWAVE Health, Inc. (Nevada corporation)
Filing Type: Form 8-K (Current Report)
Date of Report: October 10, 2023
Reporting Period: Preliminary financial results for the quarter ended September 30, 2023.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that preliminary results were announced via a press release (Exhibit 99.1), but the specific financial data is not embedded in the body of this 8-K text.
Material Changes
No material changes or comparative financial data are detailed within the text of this filing. The report references an attached press release for the actual results.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on October 10, 2023, announcing preliminary results for the quarter ended September 30, 2023.
Legal Disclaimer: The information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filing unless expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 10, 2023) for the actual preliminary financial figures.
- Verify the specific revenue and net income/loss numbers for the quarter ended September 30, 2023, as they are not listed in the 8-K summary text.
- Check for any forward-looking statements or guidance included in the attached press release.
- Confirm the status of the Company's securities registration, which is currently listed as N/A in this filing.